PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hnf1b
|
ENSMUSG00000020679.12 | Hnf1b |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hnf1b | mm39_v1_chr11_+_83741657_83741681 | 0.70 | 7.8e-12 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_89605622 | 115.81 |
ENSMUST00000049209.13
|
Gc
|
vitamin D binding protein |
chr13_-_4329421 | 101.60 |
ENSMUST00000021632.5
|
Akr1c12
|
aldo-keto reductase family 1, member C12 |
chr2_+_163389068 | 100.41 |
ENSMUST00000109411.8
ENSMUST00000018094.13 |
Hnf4a
|
hepatic nuclear factor 4, alpha |
chr8_-_5155347 | 95.74 |
ENSMUST00000023835.3
|
Slc10a2
|
solute carrier family 10, member 2 |
chr5_-_87716882 | 95.35 |
ENSMUST00000113314.3
|
Sult1d1
|
sulfotransferase family 1D, member 1 |
chr13_+_4241149 | 93.10 |
ENSMUST00000021634.4
|
Akr1c13
|
aldo-keto reductase family 1, member C13 |
chr5_+_90666791 | 82.27 |
ENSMUST00000113179.9
ENSMUST00000128740.2 |
Afm
|
afamin |
chr13_+_4283729 | 77.65 |
ENSMUST00000081326.7
|
Akr1c19
|
aldo-keto reductase family 1, member C19 |
chr19_+_43770619 | 73.14 |
ENSMUST00000026208.6
|
Abcc2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
chr10_+_62897353 | 72.33 |
ENSMUST00000178684.3
ENSMUST00000020266.15 |
Pbld1
|
phenazine biosynthesis-like protein domain containing 1 |
chr10_+_60925130 | 69.44 |
ENSMUST00000020298.8
|
Pcbd1
|
pterin 4 alpha carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 1 |
chr11_+_101258368 | 69.26 |
ENSMUST00000019469.3
|
G6pc
|
glucose-6-phosphatase, catalytic |
chr1_+_87983099 | 67.77 |
ENSMUST00000138182.8
ENSMUST00000113142.10 |
Ugt1a10
|
UDP glycosyltransferase 1 family, polypeptide A10 |
chr13_+_24023428 | 66.74 |
ENSMUST00000091698.12
ENSMUST00000110422.3 ENSMUST00000166467.9 |
Slc17a3
|
solute carrier family 17 (sodium phosphate), member 3 |
chr13_+_93810911 | 66.73 |
ENSMUST00000048001.8
|
Dmgdh
|
dimethylglycine dehydrogenase precursor |
chr1_+_88139678 | 65.90 |
ENSMUST00000073049.7
|
Ugt1a1
|
UDP glucuronosyltransferase 1 family, polypeptide A1 |
chr7_+_30193047 | 65.56 |
ENSMUST00000058280.13
ENSMUST00000133318.8 ENSMUST00000142575.8 ENSMUST00000131040.2 |
Prodh2
|
proline dehydrogenase (oxidase) 2 |
chr10_+_60925108 | 63.42 |
ENSMUST00000218005.2
|
Pcbd1
|
pterin 4 alpha carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 1 |
chr2_+_163348728 | 60.16 |
ENSMUST00000143911.8
|
Hnf4a
|
hepatic nuclear factor 4, alpha |
chr19_+_30210320 | 59.65 |
ENSMUST00000025797.7
|
Mbl2
|
mannose-binding lectin (protein C) 2 |
chr14_-_49482846 | 59.42 |
ENSMUST00000227113.2
ENSMUST00000130853.2 ENSMUST00000228936.2 ENSMUST00000022398.15 |
ccdc198
|
coiled-coil domain containing 198 |
chr1_+_88093726 | 58.85 |
ENSMUST00000097659.5
|
Ugt1a5
|
UDP glucuronosyltransferase 1 family, polypeptide A5 |
chr3_+_129630380 | 58.54 |
ENSMUST00000077918.7
|
Cfi
|
complement component factor i |
chr10_-_89369432 | 58.35 |
ENSMUST00000105297.2
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4 |
chr7_+_119773070 | 57.42 |
ENSMUST00000033201.7
|
Anks4b
|
ankyrin repeat and sterile alpha motif domain containing 4B |
chr11_+_108286114 | 56.19 |
ENSMUST00000000049.6
|
Apoh
|
apolipoprotein H |
chr3_-_82957104 | 55.69 |
ENSMUST00000048246.5
|
Fgb
|
fibrinogen beta chain |
chr1_+_87998487 | 52.94 |
ENSMUST00000073772.5
|
Ugt1a9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
chr5_+_90608751 | 52.57 |
ENSMUST00000031314.10
|
Alb
|
albumin |
chr17_+_12597490 | 52.24 |
ENSMUST00000014578.7
|
Plg
|
plasminogen |
chr6_+_90310252 | 52.09 |
ENSMUST00000046128.12
ENSMUST00000164761.6 |
Uroc1
|
urocanase domain containing 1 |
chr4_+_98919183 | 51.90 |
ENSMUST00000030280.7
|
Angptl3
|
angiopoietin-like 3 |
chr1_+_87983189 | 51.87 |
ENSMUST00000173325.2
|
Ugt1a10
|
UDP glycosyltransferase 1 family, polypeptide A10 |
chr13_+_24023386 | 50.17 |
ENSMUST00000039721.14
|
Slc17a3
|
solute carrier family 17 (sodium phosphate), member 3 |
chr13_+_23991010 | 49.37 |
ENSMUST00000006786.11
ENSMUST00000099697.3 |
Slc17a2
|
solute carrier family 17 (sodium phosphate), member 2 |
chr1_-_172722589 | 48.53 |
ENSMUST00000027824.7
|
Apcs
|
serum amyloid P-component |
chr17_-_35351026 | 48.15 |
ENSMUST00000025249.7
|
Apom
|
apolipoprotein M |
chr2_+_162829250 | 47.59 |
ENSMUST00000018012.14
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr19_+_56276375 | 47.34 |
ENSMUST00000166049.8
|
Habp2
|
hyaluronic acid binding protein 2 |
chr7_+_119160922 | 47.13 |
ENSMUST00000130583.2
ENSMUST00000084647.13 |
Acsm2
|
acyl-CoA synthetase medium-chain family member 2 |
chr5_-_87682972 | 47.12 |
ENSMUST00000120150.2
|
Sult1b1
|
sulfotransferase family 1B, member 1 |
chr1_+_88066086 | 46.78 |
ENSMUST00000014263.6
|
Ugt1a6a
|
UDP glucuronosyltransferase 1 family, polypeptide A6A |
chr13_-_93810808 | 46.27 |
ENSMUST00000015941.8
|
Bhmt2
|
betaine-homocysteine methyltransferase 2 |
chr5_-_87240405 | 45.93 |
ENSMUST00000132667.2
ENSMUST00000145617.8 ENSMUST00000094649.11 |
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr3_-_137837117 | 45.89 |
ENSMUST00000029805.13
|
Mttp
|
microsomal triglyceride transfer protein |
chr16_+_22769822 | 45.42 |
ENSMUST00000023590.9
|
Hrg
|
histidine-rich glycoprotein |
chr19_+_42034231 | 45.04 |
ENSMUST00000172244.8
ENSMUST00000081714.5 |
Hoga1
|
4-hydroxy-2-oxoglutarate aldolase 1 |
chr13_-_24098981 | 42.82 |
ENSMUST00000110407.4
|
Slc17a4
|
solute carrier family 17 (sodium phosphate), member 4 |
chr5_+_35198853 | 42.18 |
ENSMUST00000030985.10
ENSMUST00000202573.2 |
Hgfac
|
hepatocyte growth factor activator |
chr9_+_21746785 | 41.91 |
ENSMUST00000058777.8
|
Angptl8
|
angiopoietin-like 8 |
chr6_-_24168082 | 41.69 |
ENSMUST00000031713.9
|
Slc13a1
|
solute carrier family 13 (sodium/sulfate symporters), member 1 |
chr5_-_87054796 | 41.37 |
ENSMUST00000031181.16
ENSMUST00000113333.2 |
Ugt2b34
|
UDP glucuronosyltransferase 2 family, polypeptide B34 |
chr19_+_56276343 | 41.05 |
ENSMUST00000095948.11
|
Habp2
|
hyaluronic acid binding protein 2 |
chr3_-_98364359 | 41.03 |
ENSMUST00000188356.3
ENSMUST00000167753.8 |
Gm4450
|
predicted gene 4450 |
chr2_+_162829422 | 40.84 |
ENSMUST00000117123.2
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr3_-_98471301 | 40.19 |
ENSMUST00000058728.10
|
Gm10681
|
predicted gene 10681 |
chr13_-_24098951 | 39.41 |
ENSMUST00000021769.16
|
Slc17a4
|
solute carrier family 17 (sodium phosphate), member 4 |
chr4_+_138694422 | 39.30 |
ENSMUST00000116094.5
ENSMUST00000239443.2 |
Rnf186
|
ring finger protein 186 |
chr19_-_8382424 | 39.10 |
ENSMUST00000064507.12
ENSMUST00000120540.2 ENSMUST00000096269.11 |
Slc22a30
|
solute carrier family 22, member 30 |
chr11_-_11848107 | 38.62 |
ENSMUST00000178704.8
|
Ddc
|
dopa decarboxylase |
chrX_+_100419965 | 37.14 |
ENSMUST00000119080.8
|
Gjb1
|
gap junction protein, beta 1 |
chr1_-_130589349 | 36.86 |
ENSMUST00000027657.14
|
C4bp
|
complement component 4 binding protein |
chr16_+_22769844 | 36.85 |
ENSMUST00000232422.2
|
Hrg
|
histidine-rich glycoprotein |
chr4_-_106321363 | 36.63 |
ENSMUST00000049507.6
|
Pcsk9
|
proprotein convertase subtilisin/kexin type 9 |
chr11_-_75330302 | 35.37 |
ENSMUST00000043696.9
|
Serpinf2
|
serine (or cysteine) peptidase inhibitor, clade F, member 2 |
chr5_-_87485023 | 35.25 |
ENSMUST00000031195.3
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr9_-_76953070 | 35.23 |
ENSMUST00000034911.7
|
Tinag
|
tubulointerstitial nephritis antigen |
chr11_-_78313043 | 35.01 |
ENSMUST00000001122.6
|
Slc13a2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
chr1_-_130589321 | 34.73 |
ENSMUST00000137276.3
|
C4bp
|
complement component 4 binding protein |
chr11_-_75330415 | 34.27 |
ENSMUST00000128330.8
|
Serpinf2
|
serine (or cysteine) peptidase inhibitor, clade F, member 2 |
chr12_+_59142439 | 34.18 |
ENSMUST00000219140.3
|
Mia2
|
MIA SH3 domain ER export factor 2 |
chr15_+_10216041 | 34.02 |
ENSMUST00000130720.8
|
Prlr
|
prolactin receptor |
chr1_+_133237516 | 33.91 |
ENSMUST00000094557.7
ENSMUST00000192465.2 ENSMUST00000193888.6 ENSMUST00000194044.6 ENSMUST00000184603.8 |
Golt1a
Gm28040
Gm28040
|
golgi transport 1A predicted gene, 28040 predicted gene, 28040 |
chr12_-_103597663 | 33.88 |
ENSMUST00000121625.2
ENSMUST00000044231.12 |
Serpina10
|
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
chr2_-_34990689 | 32.91 |
ENSMUST00000226631.2
ENSMUST00000045776.5 ENSMUST00000226972.2 |
AI182371
|
expressed sequence AI182371 |
chr3_-_98417830 | 32.57 |
ENSMUST00000196861.2
|
Hsd3b4
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 4 |
chr11_-_11848044 | 32.56 |
ENSMUST00000066237.10
|
Ddc
|
dopa decarboxylase |
chrX_+_162873183 | 32.25 |
ENSMUST00000015545.10
|
Cltrn
|
collectrin, amino acid transport regulator |
chr13_+_55300453 | 31.26 |
ENSMUST00000005452.6
|
Fgfr4
|
fibroblast growth factor receptor 4 |
chr15_-_79169671 | 30.90 |
ENSMUST00000170955.2
ENSMUST00000165408.8 |
Baiap2l2
|
BAI1-associated protein 2-like 2 |
chr16_-_56984137 | 30.72 |
ENSMUST00000231733.2
|
Nit2
|
nitrilase family, member 2 |
chr11_-_84058292 | 30.23 |
ENSMUST00000050771.8
|
Gm11437
|
predicted gene 11437 |
chr11_+_4833186 | 30.18 |
ENSMUST00000139737.2
|
Nipsnap1
|
nipsnap homolog 1 |
chr4_-_108002186 | 30.12 |
ENSMUST00000130776.2
|
Scp2
|
sterol carrier protein 2, liver |
chr5_-_108823435 | 29.89 |
ENSMUST00000051757.14
|
Slc26a1
|
solute carrier family 26 (sulfate transporter), member 1 |
chr11_-_73217298 | 29.58 |
ENSMUST00000155630.9
|
Aspa
|
aspartoacylase |
chr7_+_51537645 | 28.01 |
ENSMUST00000208711.2
|
Gas2
|
growth arrest specific 2 |
chr9_-_106035308 | 27.89 |
ENSMUST00000159809.2
ENSMUST00000162562.2 ENSMUST00000036382.13 |
Glyctk
|
glycerate kinase |
chr13_-_73826124 | 27.59 |
ENSMUST00000022105.15
ENSMUST00000109680.10 ENSMUST00000221026.2 ENSMUST00000109679.4 |
Slc6a18
|
solute carrier family 6 (neurotransmitter transporter), member 18 |
chr2_-_164063525 | 26.37 |
ENSMUST00000018355.11
ENSMUST00000109376.9 |
Wfdc15b
|
WAP four-disulfide core domain 15B |
chr7_-_119078472 | 26.30 |
ENSMUST00000209095.2
ENSMUST00000033263.6 ENSMUST00000207261.2 |
Umod
|
uromodulin |
chr4_-_63090355 | 26.28 |
ENSMUST00000156618.9
ENSMUST00000030042.3 |
Kif12
|
kinesin family member 12 |
chr2_-_34951443 | 26.28 |
ENSMUST00000028233.7
|
Hc
|
hemolytic complement |
chr13_-_73826108 | 26.24 |
ENSMUST00000222029.2
ENSMUST00000223074.2 ENSMUST00000220650.2 ENSMUST00000221987.2 |
Slc6a18
|
solute carrier family 6 (neurotransmitter transporter), member 18 |
chr11_+_78356523 | 26.10 |
ENSMUST00000001126.4
|
Slc46a1
|
solute carrier family 46, member 1 |
chr2_+_124994425 | 25.69 |
ENSMUST00000110494.9
ENSMUST00000110495.3 ENSMUST00000028630.9 |
Slc12a1
|
solute carrier family 12, member 1 |
chrX_-_161747552 | 25.06 |
ENSMUST00000038769.3
|
S100g
|
S100 calcium binding protein G |
chr4_+_150938376 | 24.93 |
ENSMUST00000073600.9
|
Errfi1
|
ERBB receptor feedback inhibitor 1 |
chr15_+_100202079 | 24.80 |
ENSMUST00000230252.2
ENSMUST00000231166.2 |
Mettl7a1
|
methyltransferase like 7A1 |
chr13_+_54849268 | 24.76 |
ENSMUST00000037145.8
|
Cdhr2
|
cadherin-related family member 2 |
chr3_+_154302989 | 24.63 |
ENSMUST00000140644.8
ENSMUST00000144764.8 ENSMUST00000155232.2 |
Cryz
|
crystallin, zeta |
chr9_-_70841881 | 24.40 |
ENSMUST00000214995.2
|
Lipc
|
lipase, hepatic |
chr17_+_57369231 | 24.28 |
ENSMUST00000097299.10
ENSMUST00000169543.8 ENSMUST00000163763.2 |
Crb3
|
crumbs family member 3 |
chr11_+_7147779 | 23.91 |
ENSMUST00000020704.8
|
Igfbp1
|
insulin-like growth factor binding protein 1 |
chr1_-_20688196 | 23.71 |
ENSMUST00000088448.12
|
Pkhd1
|
polycystic kidney and hepatic disease 1 |
chr9_+_95441652 | 23.63 |
ENSMUST00000079597.7
|
Paqr9
|
progestin and adipoQ receptor family member IX |
chr10_-_95678786 | 23.49 |
ENSMUST00000211096.2
|
Gm33543
|
predicted gene, 33543 |
chr9_-_106035332 | 23.29 |
ENSMUST00000112543.9
|
Glyctk
|
glycerate kinase |
chr2_-_134396268 | 23.18 |
ENSMUST00000028704.3
|
Hao1
|
hydroxyacid oxidase 1, liver |
chr4_-_6275629 | 22.88 |
ENSMUST00000029905.2
|
Cyp7a1
|
cytochrome P450, family 7, subfamily a, polypeptide 1 |
chr15_+_100202061 | 22.60 |
ENSMUST00000229574.2
ENSMUST00000229217.2 |
Mettl7a1
|
methyltransferase like 7A1 |
chr5_+_65505657 | 22.46 |
ENSMUST00000031096.11
|
Klb
|
klotho beta |
chr11_+_70410445 | 22.34 |
ENSMUST00000179000.2
|
Gltpd2
|
glycolipid transfer protein domain containing 2 |
chr4_+_119494901 | 22.29 |
ENSMUST00000024015.3
|
Guca2a
|
guanylate cyclase activator 2a (guanylin) |
chr18_-_43870622 | 22.15 |
ENSMUST00000025381.4
|
Spink1
|
serine peptidase inhibitor, Kazal type 1 |
chr9_-_70842090 | 22.11 |
ENSMUST00000034731.10
|
Lipc
|
lipase, hepatic |
chr11_+_115725140 | 21.46 |
ENSMUST00000173289.8
ENSMUST00000137900.2 |
Llgl2
|
LLGL2 scribble cell polarity complex component |
chr11_-_73217633 | 21.43 |
ENSMUST00000134079.2
|
Aspa
|
aspartoacylase |
chr7_-_127494750 | 21.27 |
ENSMUST00000033074.8
|
Vkorc1
|
vitamin K epoxide reductase complex, subunit 1 |
chr15_+_100202021 | 21.01 |
ENSMUST00000230472.2
|
Mettl7a1
|
methyltransferase like 7A1 |
chr7_-_119078330 | 20.69 |
ENSMUST00000207460.2
|
Umod
|
uromodulin |
chr1_+_180878797 | 18.45 |
ENSMUST00000036819.7
|
9130409I23Rik
|
RIKEN cDNA 9130409I23 gene |
chr15_+_54274151 | 18.14 |
ENSMUST00000036737.4
|
Colec10
|
collectin sub-family member 10 |
chr7_-_44753168 | 18.10 |
ENSMUST00000211085.2
ENSMUST00000210642.2 ENSMUST00000003512.9 |
Fcgrt
|
Fc fragment of IgG receptor and transporter |
chr3_-_116506345 | 18.00 |
ENSMUST00000169530.2
|
Slc35a3
|
solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member 3 |
chr3_+_14545751 | 17.99 |
ENSMUST00000037321.8
ENSMUST00000120484.8 ENSMUST00000120801.2 |
Slc7a12
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 12 |
chr8_-_105350881 | 17.31 |
ENSMUST00000211903.2
|
Cdh16
|
cadherin 16 |
chr6_-_38101503 | 17.05 |
ENSMUST00000040259.8
|
Atp6v0a4
|
ATPase, H+ transporting, lysosomal V0 subunit A4 |
chr19_-_46661321 | 17.04 |
ENSMUST00000026012.8
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr10_-_125225298 | 16.73 |
ENSMUST00000210780.2
|
Slc16a7
|
solute carrier family 16 (monocarboxylic acid transporters), member 7 |
chr8_-_105350898 | 16.58 |
ENSMUST00000212882.2
ENSMUST00000163783.4 |
Cdh16
|
cadherin 16 |
chr7_-_28661751 | 16.21 |
ENSMUST00000068045.14
ENSMUST00000217157.2 |
Actn4
|
actinin alpha 4 |
chr6_-_52217821 | 15.67 |
ENSMUST00000121043.2
|
Hoxa10
|
homeobox A10 |
chr8_-_105350533 | 15.66 |
ENSMUST00000212662.2
|
Cdh16
|
cadherin 16 |
chr11_+_115802828 | 15.35 |
ENSMUST00000132961.2
|
Smim6
|
small integral membrane protein 6 |
chr7_-_28661648 | 15.21 |
ENSMUST00000127210.8
|
Actn4
|
actinin alpha 4 |
chr8_-_107792264 | 15.15 |
ENSMUST00000034393.7
|
Tmed6
|
transmembrane p24 trafficking protein 6 |
chr8_+_71176713 | 15.10 |
ENSMUST00000034307.14
ENSMUST00000239435.2 ENSMUST00000239487.2 ENSMUST00000110095.3 |
Pde4c
|
phosphodiesterase 4C, cAMP specific |
chr8_-_105350816 | 14.87 |
ENSMUST00000212447.2
|
Cdh16
|
cadherin 16 |
chr3_-_116506294 | 14.55 |
ENSMUST00000029569.9
|
Slc35a3
|
solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member 3 |
chr15_-_58261093 | 14.51 |
ENSMUST00000227274.3
|
Anxa13
|
annexin A13 |
chr11_+_83742961 | 14.50 |
ENSMUST00000146786.8
|
Hnf1b
|
HNF1 homeobox B |
chr9_-_119038162 | 14.40 |
ENSMUST00000084797.6
|
Slc22a13
|
solute carrier family 22 (organic cation transporter), member 13 |
chr12_-_25147139 | 14.22 |
ENSMUST00000221761.2
|
Id2
|
inhibitor of DNA binding 2 |
chr10_-_95678748 | 14.01 |
ENSMUST00000210336.2
|
Gm33543
|
predicted gene, 33543 |
chr4_+_19818718 | 14.00 |
ENSMUST00000035890.8
|
Slc7a13
|
solute carrier family 7, (cationic amino acid transporter, y+ system) member 13 |
chr5_+_31454939 | 13.89 |
ENSMUST00000201675.3
|
Gckr
|
glucokinase regulatory protein |
chr5_+_31454787 | 13.77 |
ENSMUST00000201166.4
ENSMUST00000072228.9 |
Gckr
|
glucokinase regulatory protein |
chr8_+_117822593 | 13.55 |
ENSMUST00000034308.16
ENSMUST00000176860.2 |
Bco1
|
beta-carotene oxygenase 1 |
chr18_-_66155651 | 13.45 |
ENSMUST00000143990.2
|
Lman1
|
lectin, mannose-binding, 1 |
chr19_-_46661501 | 13.30 |
ENSMUST00000236174.2
|
Cyp17a1
|
cytochrome P450, family 17, subfamily a, polypeptide 1 |
chr9_-_48516447 | 13.20 |
ENSMUST00000034808.12
ENSMUST00000119426.2 |
Nnmt
|
nicotinamide N-methyltransferase |
chr15_-_57128522 | 13.16 |
ENSMUST00000137764.2
ENSMUST00000022995.13 |
Slc22a22
|
solute carrier family 22 (organic cation transporter), member 22 |
chr15_+_99291491 | 13.04 |
ENSMUST00000159531.3
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr8_-_105350842 | 12.82 |
ENSMUST00000212324.2
|
Cdh16
|
cadherin 16 |
chr15_+_99291455 | 12.79 |
ENSMUST00000162624.8
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr11_+_114566257 | 12.58 |
ENSMUST00000045779.6
|
Ttyh2
|
tweety family member 2 |
chrX_-_137985960 | 12.44 |
ENSMUST00000033626.15
ENSMUST00000060824.4 |
Serpina7
|
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
chr5_-_38649291 | 12.10 |
ENSMUST00000129099.8
|
Slc2a9
|
solute carrier family 2 (facilitated glucose transporter), member 9 |
chr17_+_57369490 | 11.97 |
ENSMUST00000163628.2
|
Crb3
|
crumbs family member 3 |
chr1_-_136888118 | 11.93 |
ENSMUST00000192357.6
ENSMUST00000027649.14 |
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr1_+_58834621 | 11.81 |
ENSMUST00000191201.7
|
Casp8
|
caspase 8 |
chr5_-_35886605 | 11.25 |
ENSMUST00000070203.14
|
Sh3tc1
|
SH3 domain and tetratricopeptide repeats 1 |
chr1_+_130659700 | 11.18 |
ENSMUST00000039323.8
|
AA986860
|
expressed sequence AA986860 |
chr11_+_70410009 | 10.74 |
ENSMUST00000057685.3
|
Gltpd2
|
glycolipid transfer protein domain containing 2 |
chr5_-_44259010 | 10.53 |
ENSMUST00000087441.11
|
Prom1
|
prominin 1 |
chr2_+_3771709 | 10.51 |
ENSMUST00000177037.2
|
Fam107b
|
family with sequence similarity 107, member B |
chr7_-_119494669 | 10.22 |
ENSMUST00000098080.9
|
Dcun1d3
|
DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae) |
chr8_+_123920682 | 10.20 |
ENSMUST00000212409.2
|
Dpep1
|
dipeptidase 1 |
chr1_+_19279138 | 10.05 |
ENSMUST00000027059.11
|
Tfap2b
|
transcription factor AP-2 beta |
chr11_+_110858882 | 9.81 |
ENSMUST00000125692.2
|
Kcnj16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr1_-_134289670 | 9.78 |
ENSMUST00000049470.11
|
Tmem183a
|
transmembrane protein 183A |
chr7_+_140796096 | 9.54 |
ENSMUST00000153081.2
|
Rassf7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
chr5_-_44259293 | 9.48 |
ENSMUST00000074113.13
|
Prom1
|
prominin 1 |
chr12_-_8589545 | 9.36 |
ENSMUST00000095863.10
ENSMUST00000165657.3 |
Slc7a15
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 15 |
chr1_+_19279178 | 9.36 |
ENSMUST00000187754.7
|
Tfap2b
|
transcription factor AP-2 beta |
chr11_+_110858842 | 9.12 |
ENSMUST00000180023.8
ENSMUST00000106636.8 |
Kcnj16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr1_+_58834532 | 8.87 |
ENSMUST00000027189.15
|
Casp8
|
caspase 8 |
chr19_-_8196196 | 8.82 |
ENSMUST00000113298.9
|
Slc22a29
|
solute carrier family 22. member 29 |
chr3_-_144555062 | 8.76 |
ENSMUST00000159989.2
|
Clca3b
|
chloride channel accessory 3B |
chr3_+_85946145 | 8.69 |
ENSMUST00000238331.2
|
Sh3d19
|
SH3 domain protein D19 |
chr3_-_108133914 | 8.32 |
ENSMUST00000141387.4
|
Sypl2
|
synaptophysin-like 2 |
chr7_-_44711771 | 7.66 |
ENSMUST00000210101.2
ENSMUST00000209219.2 |
Prrg2
|
proline-rich Gla (G-carboxyglutamic acid) polypeptide 2 |
chr1_+_133173826 | 7.37 |
ENSMUST00000105082.9
ENSMUST00000038295.15 |
Plekha6
|
pleckstrin homology domain containing, family A member 6 |
chr4_-_150993886 | 7.33 |
ENSMUST00000128075.8
|
Park7
|
Parkinson disease (autosomal recessive, early onset) 7 |
chr10_+_101994841 | 7.22 |
ENSMUST00000020039.13
|
Mgat4c
|
MGAT4 family, member C |
chr8_+_123920233 | 7.16 |
ENSMUST00000212773.2
|
Dpep1
|
dipeptidase 1 |
chr19_+_5928649 | 7.01 |
ENSMUST00000136833.8
ENSMUST00000141362.2 |
Slc25a45
|
solute carrier family 25, member 45 |
chr16_-_92155762 | 6.47 |
ENSMUST00000166707.3
|
Kcne1
|
potassium voltage-gated channel, Isk-related subfamily, member 1 |
chr6_+_139564196 | 6.43 |
ENSMUST00000188066.2
ENSMUST00000190962.7 |
Pik3c2g
|
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma |
chr17_-_35265514 | 6.39 |
ENSMUST00000007250.14
|
Msh5
|
mutS homolog 5 |
chr7_+_130633776 | 6.18 |
ENSMUST00000084509.7
ENSMUST00000213064.3 ENSMUST00000208311.4 |
Dmbt1
|
deleted in malignant brain tumors 1 |
chr10_-_89457115 | 6.13 |
ENSMUST00000020102.14
|
Slc17a8
|
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 |
chr6_-_129077867 | 6.13 |
ENSMUST00000032258.8
|
Clec2e
|
C-type lectin domain family 2, member e |
chr17_+_74702601 | 5.83 |
ENSMUST00000024870.9
ENSMUST00000179074.9 ENSMUST00000233799.2 ENSMUST00000233042.2 |
Slc30a6
|
solute carrier family 30 (zinc transporter), member 6 |
chrX_-_137985979 | 5.74 |
ENSMUST00000152457.2
|
Serpina7
|
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
chr9_-_71070506 | 5.69 |
ENSMUST00000074465.9
|
Aqp9
|
aquaporin 9 |
chr7_-_101519872 | 5.56 |
ENSMUST00000106986.9
|
Folr1
|
folate receptor 1 (adult) |
chr3_+_69129745 | 5.42 |
ENSMUST00000183126.2
|
Arl14
|
ADP-ribosylation factor-like 14 |
chr1_+_171954316 | 5.37 |
ENSMUST00000075895.9
ENSMUST00000111252.4 |
Pex19
|
peroxisomal biogenesis factor 19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
53.5 | 160.6 | GO:1902569 | regulation of activation of JAK2 kinase activity(GO:0010534) activation of JAK2 kinase activity(GO:0042977) negative regulation of activation of JAK2 kinase activity(GO:1902569) |
28.7 | 344.1 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
27.4 | 82.3 | GO:0097037 | heme export(GO:0097037) |
24.1 | 72.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
22.6 | 90.5 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
21.9 | 65.6 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
19.8 | 178.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
17.5 | 52.6 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
16.4 | 82.2 | GO:1904970 | brush border assembly(GO:1904970) |
16.2 | 48.5 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
16.1 | 48.2 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
15.7 | 47.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
15.6 | 93.8 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
14.6 | 58.3 | GO:0038183 | histone H3-R17 methylation(GO:0034971) bile acid signaling pathway(GO:0038183) |
13.9 | 55.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
13.6 | 95.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
13.3 | 132.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
13.2 | 13.2 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
11.9 | 179.2 | GO:0015747 | urate transport(GO:0015747) |
11.7 | 47.0 | GO:0072023 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) metanephric ascending thin limb development(GO:0072218) metanephric thick ascending limb development(GO:0072233) |
11.3 | 45.0 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
10.4 | 31.3 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
10.4 | 52.1 | GO:0006548 | histidine catabolic process(GO:0006548) |
10.2 | 71.2 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
9.5 | 37.8 | GO:0052695 | cellular glucuronidation(GO:0052695) |
9.3 | 46.5 | GO:0034371 | chylomicron remodeling(GO:0034371) |
9.2 | 36.6 | GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process(GO:0032805) |
7.9 | 31.4 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
7.9 | 47.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
7.7 | 46.3 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
7.5 | 30.1 | GO:1901373 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
7.5 | 22.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
7.4 | 66.7 | GO:0019695 | choline metabolic process(GO:0019695) |
7.4 | 22.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
7.3 | 51.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
7.1 | 21.3 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
6.9 | 69.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
6.6 | 45.9 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
6.5 | 26.1 | GO:0015886 | heme transport(GO:0015886) |
6.5 | 32.6 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
6.5 | 19.4 | GO:0097275 | creatinine homeostasis(GO:0097273) cellular ammonia homeostasis(GO:0097275) cellular creatinine homeostasis(GO:0097276) cellular urea homeostasis(GO:0097277) |
6.4 | 115.8 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
6.2 | 24.9 | GO:1903243 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
6.1 | 30.5 | GO:0009441 | glycolate metabolic process(GO:0009441) |
6.1 | 18.2 | GO:0033189 | response to vitamin A(GO:0033189) |
5.7 | 34.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
5.4 | 21.5 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
5.3 | 26.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
5.2 | 25.8 | GO:0031438 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
5.1 | 25.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
5.0 | 29.9 | GO:0019532 | oxalate transport(GO:0019532) |
4.7 | 14.2 | GO:0001966 | thigmotaxis(GO:0001966) |
4.6 | 59.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
4.6 | 22.9 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
4.0 | 20.0 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
4.0 | 27.7 | GO:0009750 | response to fructose(GO:0009750) |
3.6 | 14.5 | GO:0061295 | regulation of pronephros size(GO:0035565) mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
3.5 | 219.3 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
3.4 | 30.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
3.3 | 36.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
3.3 | 101.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
3.1 | 37.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
3.1 | 21.5 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
3.0 | 41.7 | GO:0008272 | sulfate transport(GO:0008272) |
2.1 | 77.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
2.1 | 20.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.9 | 96.1 | GO:0051180 | vitamin transport(GO:0051180) |
1.4 | 21.8 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.3 | 5.1 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
1.2 | 17.0 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.2 | 32.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.2 | 67.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
1.1 | 34.2 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.0 | 30.9 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
1.0 | 11.9 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.9 | 5.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.9 | 12.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.9 | 129.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.8 | 98.6 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.8 | 13.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.7 | 3.6 | GO:0070295 | glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
0.7 | 2.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.7 | 23.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.7 | 107.7 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.7 | 4.0 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) mammary gland branching involved in pregnancy(GO:0060745) |
0.6 | 3.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 2.5 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.5 | 18.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.5 | 3.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.5 | 15.7 | GO:0060065 | uterus development(GO:0060065) |
0.4 | 23.7 | GO:0010824 | regulation of centrosome duplication(GO:0010824) negative regulation of protein kinase B signaling(GO:0051898) |
0.4 | 4.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 8.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.4 | 4.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 15.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.4 | 5.8 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.4 | 3.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 6.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.3 | 10.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 3.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 4.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 2.5 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 6.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 5.5 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 2.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
0.2 | 18.1 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.1 | 22.0 | GO:0006865 | amino acid transport(GO:0006865) |
0.1 | 28.0 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.1 | 13.5 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 18.0 | GO:0006814 | sodium ion transport(GO:0006814) |
0.1 | 0.5 | GO:0009816 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 2.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 2.9 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 3.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 8.5 | GO:0006821 | chloride transport(GO:0006821) |
0.1 | 11.5 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 19.0 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.1 | 18.0 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 13.5 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 8.0 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 1.9 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 7.0 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.0 | 45.7 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 0.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 1.1 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
27.4 | 82.3 | GO:0061474 | phagolysosome membrane(GO:0061474) |
13.9 | 125.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
12.2 | 36.6 | GO:1990667 | PCSK9-LDLR complex(GO:1990666) PCSK9-AnxA2 complex(GO:1990667) |
9.6 | 48.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
8.7 | 52.2 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
4.4 | 65.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
4.1 | 20.7 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
4.1 | 73.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
3.3 | 26.3 | GO:0005579 | membrane attack complex(GO:0005579) |
3.0 | 56.2 | GO:0042627 | chylomicron(GO:0042627) |
2.9 | 20.0 | GO:0071914 | prominosome(GO:0071914) |
2.5 | 24.8 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
2.4 | 30.9 | GO:0071439 | clathrin complex(GO:0071439) |
2.3 | 30.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
2.1 | 17.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.8 | 46.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.5 | 31.4 | GO:0031143 | pseudopodium(GO:0031143) |
1.4 | 4.2 | GO:1904602 | serotonin-activated cation-selective channel complex(GO:1904602) |
1.4 | 37.1 | GO:0005922 | connexon complex(GO:0005922) |
1.3 | 183.3 | GO:0005902 | microvillus(GO:0005902) |
1.2 | 58.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.2 | 298.3 | GO:0072562 | blood microparticle(GO:0072562) |
1.1 | 38.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.9 | 97.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.9 | 6.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.7 | 13.5 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.7 | 270.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.7 | 77.8 | GO:0005581 | collagen trimer(GO:0005581) |
0.7 | 4.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.7 | 68.4 | GO:0005811 | lipid particle(GO:0005811) |
0.6 | 6.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.6 | 2.8 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.5 | 2.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 12.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.4 | 42.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.4 | 121.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 166.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.3 | 198.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 1.2 | GO:0044299 | C-fiber(GO:0044299) |
0.3 | 35.2 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 50.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 884.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 45.9 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 306.8 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.2 | 6.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 24.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 23.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 17.6 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.1 | 2.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 17.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 30.3 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 86.7 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 6.9 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 100.6 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 1.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 15.4 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
53.5 | 160.6 | GO:0070540 | stearic acid binding(GO:0070540) |
44.3 | 132.9 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
29.0 | 115.8 | GO:1902271 | D3 vitamins binding(GO:1902271) |
28.5 | 142.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
27.4 | 82.3 | GO:0008431 | vitamin E binding(GO:0008431) |
19.4 | 58.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
17.8 | 71.2 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
17.3 | 69.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
17.0 | 51.0 | GO:0019807 | aspartoacylase activity(GO:0019807) |
16.7 | 66.7 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
15.5 | 248.5 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
13.2 | 39.5 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
12.0 | 95.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
11.4 | 469.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
11.3 | 45.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
9.4 | 56.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
9.3 | 46.5 | GO:0035478 | chylomicron binding(GO:0035478) |
7.5 | 30.1 | GO:1904121 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
7.5 | 59.7 | GO:0005534 | galactose binding(GO:0005534) |
7.2 | 194.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
7.1 | 21.3 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
6.8 | 34.0 | GO:0004925 | prolactin receptor activity(GO:0004925) |
6.4 | 25.7 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
6.3 | 25.1 | GO:0005499 | vitamin D binding(GO:0005499) |
6.2 | 24.6 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
6.1 | 48.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
5.9 | 47.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
5.8 | 23.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
5.8 | 46.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
5.5 | 66.1 | GO:0019864 | IgG binding(GO:0019864) |
5.2 | 20.7 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
4.7 | 51.9 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
4.7 | 98.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
4.6 | 18.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
4.4 | 26.1 | GO:0015232 | heme transporter activity(GO:0015232) |
4.3 | 25.8 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
4.0 | 60.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
3.8 | 71.6 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
3.7 | 22.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
3.4 | 88.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
3.1 | 21.5 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
2.8 | 31.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.8 | 52.6 | GO:0015643 | toxic substance binding(GO:0015643) |
2.8 | 27.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
2.5 | 17.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
2.4 | 23.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.1 | 37.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
2.1 | 6.2 | GO:0035375 | zymogen binding(GO:0035375) |
2.0 | 32.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
1.9 | 9.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
1.8 | 7.3 | GO:0036470 | tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
1.8 | 65.6 | GO:0071949 | FAD binding(GO:0071949) |
1.7 | 53.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
1.5 | 30.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.4 | 31.6 | GO:0005537 | mannose binding(GO:0005537) |
1.3 | 4.0 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
1.3 | 14.5 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
1.3 | 215.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.3 | 13.8 | GO:0051870 | methotrexate binding(GO:0051870) |
1.3 | 32.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
1.1 | 3.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
1.0 | 27.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.9 | 49.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.9 | 30.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.8 | 4.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.8 | 17.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.7 | 22.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.7 | 52.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.7 | 2.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.7 | 7.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 138.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.6 | 22.9 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.6 | 5.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.6 | 47.5 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.5 | 72.1 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.5 | 73.1 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.5 | 18.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.5 | 53.2 | GO:0016209 | antioxidant activity(GO:0016209) |
0.5 | 55.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.4 | 31.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.4 | 13.5 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.4 | 35.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.4 | 6.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 10.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.4 | 15.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.3 | 60.0 | GO:0016853 | isomerase activity(GO:0016853) |
0.3 | 30.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.2 | 6.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 18.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 21.1 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 16.5 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 5.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 2.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 21.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 10.4 | GO:0015293 | symporter activity(GO:0015293) |
0.1 | 3.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 14.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 4.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 2.9 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 1.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.0 | 21.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 2.5 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 7.4 | GO:0005543 | phospholipid binding(GO:0005543) |
0.0 | 13.5 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 312.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.9 | 110.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.3 | 20.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.0 | 58.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.9 | 245.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.6 | 34.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.6 | 51.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.5 | 53.7 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 15.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 28.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 57.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 7.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 41.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 14.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 44.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 6.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 4.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 15.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 5.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 3.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.4 | 180.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
13.5 | 148.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
7.5 | 59.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
5.8 | 98.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
4.6 | 160.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
4.2 | 58.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
3.5 | 55.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
3.4 | 47.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
3.3 | 94.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
3.2 | 71.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
3.0 | 124.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
2.8 | 53.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
2.4 | 50.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.4 | 21.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.3 | 53.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
1.8 | 78.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
1.7 | 48.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.7 | 96.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.6 | 37.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.5 | 183.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.5 | 31.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.4 | 48.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.4 | 22.5 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
1.3 | 26.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.2 | 34.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.0 | 12.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.8 | 204.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.8 | 32.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.7 | 43.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.7 | 9.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.6 | 32.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.5 | 25.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.4 | 57.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 15.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 18.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 6.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 13.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 4.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 4.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 3.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 4.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |